| pubmed-article:19721480 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19721480 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
| pubmed-article:19721480 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19721480 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19721480 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:19721480 | pubmed:dateCreated | 2009-9-1 | lld:pubmed |
| pubmed-article:19721480 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:abstractText | Standardized treatment (24-week) with pegylated interferon and ribavirin induces sustained virological response in 80 % of patients with Hepatitis C (HCV) genotype 2 or 3. Most patients who are dependent on heroin and receiving methadone maintenance therapy (MMT) have been excluded from this treatment due to concerns about compliance. Short-term therapy (14 weeks) of other patient groups have shown promising results. The purpose of this study was to investigate the feasibility, efficacy and adverse effects of short-term treatment in a group of MMT patients with chronic hepatitis C infection genotype 3. | lld:pubmed |
| pubmed-article:19721480 | pubmed:language | nor | lld:pubmed |
| pubmed-article:19721480 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19721480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19721480 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19721480 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19721480 | pubmed:issn | 0807-7096 | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:SundøyAndersA | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:GallefossFrod... | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:RysstadOleO | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:KristensenØis... | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:VederhusJohn-... | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:SkeieKarinK | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:ØyeIngebjørgI | lld:pubmed |
| pubmed-article:19721480 | pubmed:author | pubmed-author:OpsalAnneA | lld:pubmed |
| pubmed-article:19721480 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19721480 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:19721480 | pubmed:volume | 129 | lld:pubmed |
| pubmed-article:19721480 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19721480 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19721480 | pubmed:pagination | 1639-42 | lld:pubmed |
| pubmed-article:19721480 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:meshHeading | pubmed-meshheading:19721480... | lld:pubmed |
| pubmed-article:19721480 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19721480 | pubmed:articleTitle | [Short-term treatment of Hepatitis C in heroin-dependent patients]. | lld:pubmed |
| pubmed-article:19721480 | pubmed:affiliation | Avdeling for rus- og avhengighetsbehandling, Sørlandet sykehus, 4604 Kristiansand, Norway. oistein.kristensen@sshf.no | lld:pubmed |
| pubmed-article:19721480 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19721480 | pubmed:publicationType | English Abstract | lld:pubmed |
